This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Clinical Trial Results
The SONATA Clinical Trial
Women were surveyed 12 months after their Sonata Treatment and reported the following results:
- 97% would recommend Sonata treatment to a friend
- 95% reported a reduction in menstrual bleeding
- 50% returned to normal activity the next day
Reference: Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas: The SONATA Trial. Obstet Gynecol. 2019 Jan; 133(1): 13-22